Hinge Health, Inc. (HNGE) Financial Statements

Income statement

Metric	TTM	2025	2024	2023
Revenue
Total Revenue	800.8M	587.9M	390.4M	292.7M
Cost of Revenue	114.1M	118.6M	89.8M	98.6M
Gross Profit	686.7M	469.3M	300.6M	194.2M
Operating Expenses
R&D Expense	134.6M	368.1M	100.8M	110.1M
SG&A Expense	401.3M	639.4M	227.5M	214.6M
General & Admin Expense	106.7M	325.5M	62.4M	67.0M
Selling & Marketing Expense	294.6M	313.9M	165.1M	147.6M
Other Expenses	665.0K	8.1M	4.1M	—
Total Operating Expenses	536.6M	1.0B	332.5M	324.7M
Cost and Expenses	650.7M	1.1B	422.3M	423.2M
Operating Income (EBIT)	150.1M	(546.4M)	(31.9M)	(130.5M)
Non-Operating
Interest Income	—	—	—	—
Interest Expense	—	—	—	—
Net Interest Income	—	—	—	—
Other Non-Op Income/Expense	16.2M	19.1M	20.7M	22.0M
Non-Operating Income (excl Interest)	(8.6M)	(5.4M)	(7.5M)	—
EBT (Pre-Tax Income)	166.3M	(527.3M)	(11.3M)	(108.5M)
Income Tax Expense	(2.0M)	998.0K	677.0K	(405.0K)
Bottom Line
Net Income	168.3M	(528.3M)	(11.9M)	(108.1M)
Earnings from Cont. Ops	168.3M	(528.3M)	(11.9M)	(108.1M)
Earnings from Discont. Ops	—	—	—	—
Bottom Line Net Income	165.6M	(424.1M)	(11.9M)	(108.1M)
Per Share
Basic EPS	$2.08	($5.36)	($0.15)	($1.39)
Diluted EPS	$1.97	($5.19)	($0.15)	($1.39)
Revenue Per Share	$9.90	$7.42	$5.00	$3.75
Shares
Basic Shares Outstanding	80.9M	79.2M	78.0M	78.0M
Diluted Shares Outstanding	86.5M	81.7M	78.0M	78.0M
Profitability Metrics
EBITDA	164.4M	(535.9M)	(18.5M)	(124.9M)
D&A	5.7M	5.1M	6.0M	5.6M
EBIT	158.7M	(541.0M)	(24.4M)	(130.5M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026